Mitsubishi Chemical : Diabetes Care goes digital as RSSDI partners with Wellthy Therapeutics 4-Traders

New Delhi [India], Dec 21 (ANI-BusinessWireIndia): The Research Society for The Study of Diabetic in India (RSSDI) has partnered with Wellthy Therapeutics, a digital therapeutics company focused on improving diabetes care and outcomes through Artificial Intelligence. Wellthy Diabetes is an artificial intelligence powered diabetes health coach for patients and a virtual clinical assistant for doctors. This is a first of its kind RSSDI endorsement for an application that can be prescribed by doctors to patients. The partnership was announced at the recently concluded annual RSSDI conference held in Hyderabad. Over the last 20 years, billions of dollars have been spent on pharma and med device research.